Pauline D Menard, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 106 Heymann Blvd, Lafayette, LA 70503 Phone: 337-504-4279 |
Joshua Paul Daigle, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 3149 Ambassador Caffery Pkwy, Lafayette, LA 70506 Phone: 337-261-0734 |
Brakeisha Lashay Broussard, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 312 Liston St, Lafayette, LA 70501 Phone: 337-565-9737 |
News Archive
Blue light can both set the mood and set in motion important biological responses. Researchers at the University of Pennsylvania's School of Medicine and School of Arts and Sciences have teased apart the separate biological responses of the human eye to blue light, revealing an unexpected contest for control.
The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients aged 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus.
Today the U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee voted overwhelmingly (13 to 2) to recommend BENLYSTA® for approval as a treatment for the autoimmune disease lupus. If FDA approved, BENLYSTA would become the first new treatment for lupus in 52 years. While today's vote is a positive step, the FDA still must make a final decision to approve BENLYSTA in the coming weeks.
Kisspeptin neurons appear to play a role in hypogonadotropic anovulation caused by excessive levels of prolactin, research shows.
Recent work in mice suggested that the immune system is involved in removing beta-amyloid, the main Alzheimer's-causing substance in the brain. Researchers have now shown for the first time that this may apply in humans.
› Verified 6 days ago